Old West Investment Management’s Heron Therapeutics HRTX Stock Holding History

Old West Investment Management’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,873	Closed	-$422K	–	91
2018 Q2	$422K	Buy	10,873 +444	+4%	+$14.1K	0.21%	64
2018 Q1	$287K	Sell	10,429 -7,730	-43%	-$175K	0.17%	70
2017 Q4	$328K	Buy	18,159 +6,589	+57%	+$107K	0.19%	62
2017 Q3	$186K	Sell	11,570 -979	-8%	-$15.4K	0.1%	63
2017 Q2	$173K	Sell	12,549 -1,216	-9%	-$17.6K	0.09%	66
2017 Q1	$206K	Buy	+13,765	New	+$191K	0.11%	58

Other funds holding HRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Old West Investment Management's HRTX Position: Q3 2018 in Review

Old West Investment Management sold out of Heron Therapeutics (HRTX) in Q3 2018, closing a stake of 10,873 shares — an estimated $422K sold.

Old West Investment Management first reported a position in HRTX in Q1 2017 and held it in 6 quarters. The position peaked at $422K in Q2 2018. 194 funds tracked by Wall St. Rank hold HRTX as of Q3 2018.

Old West Investment Management reported no remaining Heron Therapeutics position as of Q3 2018 after selling out during the quarter.
Old West Investment Management sold 10,873 Heron Therapeutics shares in Q3 2018, an estimated $422K.
Old West Investment Management first reported a position in Heron Therapeutics in Q1 2017 and held it in 6 quarters.
Old West Investment Management's Heron Therapeutics position peaked at $422K in Q2 2018.
194 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2018.

Based on Old West Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.